0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Clinical Challenge | 
Meredith E. Clement, MD; N. Lance Okeke, MD; Charles B. Hicks, MD
JAMA. 2015;314(4):400-402. doi:10.1001/jama.2015.3401.

Capitol Health Call | 
Laura Buchholz
JAMA. 2015;314(2):115. doi:10.1001/jama.2015.7534.

News From the Centers for Disease Control and Prevention | 
JAMA. 2015;313(24):2417. doi:10.1001/jama.2015.6481.

Review | 
Mary E. Rinella, MD
JAMA. 2015;313(22):2263-2273. doi:10.1001/jama.2015.5370.
Includes: CME, Supplemental Content

JAMA Clinical Guidelines Synopsis | 
Charlie M. Wray, DO; Andrew M. Davis, MD, MPH
JAMA. 2015;313(18):1855-1856. doi:10.1001/jama.2015.2833.

From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2015;313(18):1857-1858. doi:10.1001/jama.2015.4562.

Editorial | 
Hari Conjeevaram, MD, MSc
JAMA. 2015;313(17):1716-1717. doi:10.1001/jama.2015.4368.

News From the Food and Drug Administration | 
Rita Rubin, MA
JAMA. 2015;313(17):1704. doi:10.1001/jama.2015.4116.

Original Investigation | 
Fred Poordad, MD; William Sievert, MD; Lindsay Mollison, MD; et al.
JAMA. 2015;313(17):1728-1735. doi:10.1001/jama.2015.3860.
Includes: CME, Supplemental Content

Original Investigation | 
Andrew J. Muir, MD; Fred Poordad, MD; Jacob Lalezari, MD; et al.
JAMA. 2015;313(17):1736-1744. doi:10.1001/jama.2015.3868.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Internal Medicine
Evidence to Practice  | 
Comparative Clinical Effectiveness and Value of Novel Interferon-Free Combination Therapy for Hepatitis C Genotype 1: Summary of California Technology Assessment Forum Report
Jeffrey A. Tice, MD; Harinder S. Chahal, PharmD, MSc; Daniel A. Ollendorf, PhD
JAMA Internal Medicine
Invited Commentary  | 
The Subtle Benefit of Anticoagulant Therapy for Splanchnic Vein Thrombosis
Jack Ansell, MD
JAMA Internal Medicine
Original Investigation  | 
Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry
Walter Ageno, MD; Nicoletta Riva, MD; Sam Schulman, MD; et al.
JAMA Oncology
Editor's Note  | 
Dual-Modality Liver-Directed Therapy for Primary Liver Cancer
Charles R. Thomas Jr, MD